BioGaia AB (publ)
OTC: BIOGY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Theresa Agnew
- Employees
- 224
- Headquarters
- Stockholm, Sweden
- IPO year
- 2021
- Market cap
- $1.1B
- Website
- https://www.biogaia.com
Loading BIOGY…
Loading profile data…Frequently asked questions about BIOGY
What does BioGaia AB (publ) (BIOGY) do?
BioGaia AB (publ) is a global enterprise dedicated to the development, marketing, and sale of probiotic products, all backed by documented health benefits. The company organizes its activities into three primary divisions: Pediatrics, Adult Health, and 'Other'. Within the Pediatric segment, BioGaia provides items such as liquid drops, oral rehyd...
Where does BIOGY trade?
BioGaia AB (publ) (BIOGY) trades on the Other OTC.
What sector is BIOGY in?
BioGaia AB (publ) (BIOGY) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of BioGaia AB (publ)?
Theresa Agnew is the chief executive officer of BioGaia AB (publ) (BIOGY).
Where is BioGaia AB (publ) headquartered?
BioGaia AB (publ) is headquartered in Sweden.
Does BIOGY pay a dividend?
Yes — BioGaia AB (publ) (BIOGY) paid a trailing twelve-month dividend of USD 0.42 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did BIOGY go public?
BioGaia AB (publ) (BIOGY) completed its initial public offering in 2021.
Is BIOGY an ADR?
Yes — BIOGY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. BioGaia AB (publ) reporting and dividends follow the underlying issuer.